Holding(s) in Company

Summary by AI BETAClose X

Aberdeen Group plc, through abrdn Holdings Limited and abrdn Inc., increased its stake in 4basebio PLC to 7.571253% of voting rights, representing 1,456,310 shares, following participation in a Placing that completed on 10 November 2026; the position was notified on 11 November 2026, contains 0.000000% exposure via financial instruments, and the voting rights are held in discretionary client portfolios with delegated voting authority.

Disclaimer*

Companies

4basebio (4BB)
UK 100

Latest directors dealings